LRP6 and coronary artery disorder: As WNT signaling is involved in many processes of organogenesis and tissue homeostasis, mutations in LRP6 have been linked to various diseases [18] including coronary artery disease (CAD) [19], high bone mass (HBM) phenotypes [20], and neural tube defects (NTDs) [21].